@incollection{,
	
					
					
					C384065913E24A7C40EDBBDF38DB9B6C
				,
	author={{Dr. Sujan NarayanAgrawal}},
	journal={{Global Journal of Medical Research}},
	journal={{GJMR}}2249-46180975-588810.34257/GJMR,
	address={Cambridge, United States},
	publisher={Global Journals Organisation}2121923
}

@incollection{b0,
	
	
		,
	title={{The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2): A Review of the Basics}}
		,
	author={{
			Dr
		} and {
			Sujan Narayan Agrawal
		}}
		
		10.36348/sjpm.2020.v05i07.002
	
	
		,
	journal={{Saudi J PatholMicrobiol}}
		2518-3362 (Print) | 2518-3370
		
			5
			7
			
			,
	year={2020}
		
	

}

@incollection{b1,
	
	
		,
	title={{Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding}}
		,
	author={{
			RLu
		} and {
			XZhao
		} and {
			JLi
		} and {
			PNiu
		} and {
			BYang
		} and {
			HWu
		}}
		
		
		
		
		
	
	
		,
	journal={{Lancet}}
		
			6736
			
			,
	year={2020}
		
	

}

@incollection{b2,
	
	
		,
	title={{A pneumonia outbreak associated with a new coronavirus of probable bat origin}}
		,
	author={{
			PZhou
		} and {
			X.-LYang
		} and {
			X.-GWang
		} and {
			BHu
		} and {
			LZhang
		} and {
			WZhang
		}}
		
		
		
		
		
	
	
		,
	journal={{Nature}}
		
			,
	year={2020}
		
	
	,
	note={PubMed}

}

@incollection{b3,
	
	
		,
	title={{Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding}}
		,
	author={{
			RLu
		} and {
			XZhao
		} and {
			JLi
		} and {
			PNiu
		} and {
			BYang
		} and {
			HWu
		}}
		
		
		
		
		
	
	
		,
	journal={{Lancet}}
		
			6736
			
			,
	year={2020}
		
	

}

@book{b4,
	
	
		,
	title={{Functional assessment of cell entry and receptor usage for lineage B_-coronaviruses}}
		,
	author={{
			MLetko
		} and {
			VMunster
		}}
		
		
	
	,
	note={including 2019-nCoV. bioRxiv2020, 2020.01.22.915660}

}

@book{b5,
	
	
		,
	title={{The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells}}
		,
	author={{
			MHomann
		} and {
			HKleine-Weber
		} and {
			NKruger
		} and {
			MMuller
		} and {
			CDrosten
		} and {
			SPohlmann
		}}
		
		
		
		
		
		bioRxiv2020, 2020.01. 31.929042
		
	

}

@incollection{b6,
	
	
		,
	title={{A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice}}
		,
	author={{
			Z.-YYang
		} and {
			W.-PKong
		} and {
			YHuang
		} and {
			ARoberts
		} and {
			BRMurphy
		} and {
			KSubbarao
		}}
		
		
		
		
		
	
	
		,
	journal={{Nature}}
		
			428
			
			,
	year={2004}
		
	

}

@incollection{b7,
	
	
		,
	title={{A live, impairedfidelity coronavirus vaccine protects in an aged, immunocompromised mouse model of lethal disease}}
		,
	author={{
			RLGraham
		} and {
			MMBecker
		} and {
			LDEckerle
		} and {
			MBolles
		} and {
			MRDenison
		} and {
			RSBaric
		}}
		
		
		
		
		
	
	
		,
	journal={{Nat. Med}}
		
			18
			
			,
	year={2012}
		
	
	,
	note={PubMed}

}

@incollection{b8,
	
	
		,
	title={{Identification of an epitope of SARScoronavirus nucleocapsid protein}}
		,
	author={{
			YLin
		} and {
			XShen
		} and {
			RFYang
		} and {
			YXLi
		} and {
			YYJi
		} and {
			YYHe
		}}
		
		
		
		
		
	
	
		,
	journal={{Cell Res}}
		
			13
			
			,
	year={2003}
		
	
	,
	note={PubMed}

}

@incollection{b9,
	
	
		,
	title={{Profile of antibodies to the nucleocapsid protein of the severe acute respiratory syndrome (SARS)-associated coronavirus in probable SARS patients}}
		,
	author={{
			XLiu
		} and {
			YShi
		} and {
			PLi
		} and {
			LLi
		} and {
			YYi
		} and {
			QMa
		}}
		
		
		
		
		
	
	
		,
	journal={{Clin. Vaccine Immunol}}
		
			11
			
			,
	year={2004}
		
	
	,
	note={PubMed}

}

@incollection{b10,
	
	
		,
	title={{Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome: A six-year follow-up study}}
		,
	author={{
			FTang
		} and {
			YQuan
		} and {
			Z.-TXin
		} and {
			JWrammert
		} and {
			M.-JMa
		} and {
			HLv
		}}
		
		
		
		
		
	
	
		,
	journal={{J. Immunol}}
		
			186
			
			,
	year={2011}
		
	

}

@incollection{b11,
	
	
		,
	title={{Long-lived memory T lymphocyte responses against SARS coronavirus nucleocapsid protein in SARS-recovered patients}}
		,
	author={{
			HPeng
		} and {
			L.-TYang
		} and {
			L.-YWang
		} and {
			JLi
		} and {
			JHuang
		} and {
			Z.-QLu
		}}
		
		
		
		
		
	
	
		,
	journal={{Virology}}
		
			351
			
			,
	year={2006}
		
	

}

@incollection{b12,
	
	
		,
	title={{Characterization of SARS-CoVspecific memory T cells from recovered individuals 4 years after infection}}
		,
	author={{
			Y.-YFan
		} and {
			Z.-THuang
		} and {
			LLi
		} and {
			M.-HWu
		} and {
			TYu
		} and {
			RAKoup
		}}
		
		
		
		
		
	
	
		,
	journal={{Arch. Virol}}
		
			154
			
			,
	year={2009}
		
	

}

@incollection{b13,
	
	
		,
	title={{T cell responses to whole SARS coronavirus in humans}}
		,
	author={{
			CKLi
		} and {
			.-FWu
		} and {
			HYan
		} and {
			HMa
		} and {
			SWang
		} and {
			LZhang
		} and {
			M
		}}
		
		
		
		
		
		
	
	
		,
	journal={{J. Immunol}}
		
			181
			
			,
	year={2008}
		
	

}

@incollection{b14,
	
	
		,
	title={{Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection}}
		,
	author={{
			RChannappanavar
		} and {
			CFett
		} and {
			JZhao
		} and {
			DKMeyerholz
		} and {
			SPerlman
		}}
		
		
		
		
	
	
		,
	journal={{J. Virol}}
		
			88
			
			,
	year={2014}
		
	
	,
	note={PubMed}

}

@incollection{b15,
	
	
		,
	title={{Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses}}
		,
	author={{
			WangNing
		} and {
			Jian
		} and {
			Shang
		} and {
			Shibo
		} and {
			Jiang
		} and {
			DuLanying
		}}
		
		
		
		
		
		10.3389/fmicb.2020.%2000298
		
	
	
		,
	journal={{Frontiers in Microbiology}}
		
			,
	year={2020}
		
	

}

@incollection{b16,
	
	
		,
	title={{The COVID-19 vaccine development landscape}}
		,
	author={{
			TungLe
		} and {
			Thanh
		} and {
			Andreadakis
		} and {
			Zacharias
		} and {
			Kumar
		} and {
			Arun
		} and {
			Rom´an
		}}
		
		
		
		
		
		
	
	
		,
	journal={{Nature Reviews Drug Discovery}}
		
			19
			5
			
			,
	year={2020. 2020}
		
	

}

@incollection{b17,
	
	
		,
	title={{SARS coronavirus nucleocapsid immunodominant T-cell epitope cluster is common to both exogenous recombinant and endogenous DNA-encoded immunogens}}
		,
	author={{
			VGupta
		} and {
			TMTabiin
		} and {
			KSun
		} and {
			AChandrashekaran
		} and {
			AAnwar
		} and {
			KYang
		}}
		
		
		
		
		
	
	
		,
	journal={{Virology}}
		
			347
			1
			
			,
	year={2006}
		
	
	,
	note={impact factor: 2.657}

}

@incollection{b18,
	
	
		,
	title={{Immunoinformaticsaided identification of T cell and B cell epitopes in the surface glycoprotein of 2019-nCoV}}
		,
	author={{
			VBaruah
		} and {
			SBose
		}}
		
		10.1002/jmv.25698
		
	
	
		,
	journal={{J Med Virol}}
		
			
			,
	year={2020}
		
	

}

@incollection{b19,
	
	
		,
	title={{DNA Vaccines-How Far from Clinical Use?}}
		,
	author={{
			DHobernik
		} and {
			MBros
		}}
		
		10.3390/ijms19113605
		30445702
		PMC6274812
		
	
	
		,
	journal={{Int J Mol Sci}}
		
			3605
			,
	year={2018. 2018}
		
	

}

@book{b20,
	
	
		,
	title={{Phase 1/2 Study to Describe the Safety and Immunogenicity of a COVID-19 RNA Vaccine Candidate (BNT162b1) in Adults 18 to 55 Years of Age: Interim Report}}
		,
	author={{
			MarkJMulligan
		} and {
			KirstenELyke
		}}
		
		
			,
	year={2020}
		
	
	,
	note={preprint. s.l.medRxiv, 06.30.20142570, 2020, medRxiv}

}

@incollection{b21,
	
	
		,
	title={{A Review of SARS-CoV-2 and the Ongoing Clinical Trials}}
		,
	author={{
			Y.-FTu
		} and {
			C.-SChien
		} and {
			AAYarmishyn
		} and {
			Y.-YLin
		} and {
			Y.-HLuo
		} and {
			Y.-YLin
		}}
		
		
		
		
		
	
	
		,
	journal={{International Journal of Molecular Sciences}}
		
			,
	year={2020. 2657}
		
	

}

@book{b22,
	
	
		,
	title={{Phase 1/2 Study to Describe the Safety and Immunogenicity of a COVID-19 RNA Vaccine Candidate (BNT162b1) in Adults 18 to 55 Years of Age: Interim Report}}
		,
	author={{
			MarkJMulligan
		} and {
			KirstenELyke
		}}
		
		
			,
	year={2020}
		
	
	,
	note={preprint. s.l.: medRxiv, 06.30.20142570, 2020, medRxiv}

}

@book{b23,
	
	
		,
	title={{HKU joins global partnership to develop COVID-19 vaccine}}
		,
	author={{
			Anon
		}}
		
		
			,
	year={2020j. March 18, 2020}
		
		
			The University of Hong Kong
		
	

}

@incollection{b24,
	
	
		,
	title={{Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses}}
		,
	author={{
			WangNing
		} and {
			Jian
		} and {
			Shang
		} and {
			Shibo
		} and {
			Jiang
		} and {
			DuLanying
		}}
		
		
		
		
		
		10.3389/fmicb.2020.00298
		
	
	
		,
	journal={{Frontiers in Microbiology}}
		
			,
	year={2020}
		
	

}

@incollection{b25,
	
	
		,
	title={{Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses}}
		,
	author={{
			WangNing
		} and {
			Jian
		} and {
			Shang
		} and {
			Shibo
		} and {
			Jiang
		} and {
			DuLanying
		}}
		
		
		
		
		
		10.3389/fmicb.2020.00298
		
	
	
		,
	journal={{Frontiers in Microbiology}}
		
			,
	year={2020}
		
	

}

@incollection{b26,
	
	
		,
	title={{Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice}}
		,
	author={{
			ChristopherMColeman
		} and {
			YeVLiu
		} and {
			Mu
		} and {
			Haiyan
		} and {
			JustinKTaylor
		} and {
			Massare
		} and {
			Michael
		} and {
			DavidCFlyer
		}}
		
		
		
		
		
		
		
		10.1016/j.vaccine.2014.04.016
		
	
	
		,
	journal={{Vaccine}}
		
			
			,
	year={2020}
		
	

}

@book{b27,
	
	
		,
	title={{Clinical Trials Arena}}
		
		
			,
	year={2020}
		
	
	,
	note={Novavax covid 19 vaccine trial}

}

@book{b28,
	
	
		,
	title={{Developments in Viral Vector-Based Vaccines. Vaccines (Basel) 624-641}}
		,
	author={{
			TUra
		} and {
			KOkuda
		} and {
			MShimada
		}}
		
		
		10.3390/vaccines2030624
		26344749
		PMC4494222
		
		
			,
	year={2014}
		
	

}

@incollection{b29,
	
	
		,
	title={{The COVID-19 vaccine development landscape}}
		,
	author={{
			TungLe
		} and {
			Thanh
		} and {
			Andreadakis
		} and {
			Zacharias
		} and {
			Kumar
		} and {
			Arun
		} and {
			RaúlRom´an
		} and {
			G´omez
		}}
		
		
		
		
		
		
		
	
	
		,
	journal={{Nature Reviews Drug Discovery}}
		
			19
			5
			
			,
	year={2020}
		
	

}

@incollection{b30,
	
	
		,
	title={{Biochemical method for inserting new genetic information into DNA of Simian Virus 40: circular SV40 DNA molecules containing lambda phage genes and the galactose operon of Escherichia coli}}
		,
	author={{
			DAJackson
		} and {
			RHSymons
		} and {
			PBerg
		}}
		
		
	
	
		,
	journal={{Proc Natl Acad Sci U S A}}
		
			69
			
			,
	year={1972}
		
	

}

@incollection{b31,
	
	
		,
	title={{Vaccinia virus: a selectable eukaryotic cloning and expression vector}}
		,
	author={{
			MMackett
		} and {
			GLSmith
		} and {
			BMoss
		}}
		
		
	
	
		,
	journal={{Proc Natl Acad Sci U S A}}
		
			79
			
			,
	year={1982}
		
	

}

@book{b32,
	
	
		,
	title={{Safety, tolerability, and immunogenicity of a recombinantadenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, openlabel, nonrandomised, first-in-human trial. The Lancet}}
		,
	author={{
			Feng-CaiZhu
		} and {
			LiYu-Hua
		} and {
			Guan
		} and {
			Xu-Hua
		}}
		
		
		
		10.1016/S0140-6736(20
		
		
			,
	year={2020}
			
		
	

}

@book{b33,
	
	
		,
	title={{}}
		,
	author={{
			2020eAnon
		} and {
			Uw-Madison
		} and {
			BharatFlugen
		} and {
			Biotech
		} and {
			Develop Coroflu
		}}
		
		
		
		
		
		
			,
	year={April 02}
		
	

}

@book{b34,
	
	
		,
	title={{These 23 companies are working on coronavirus treatments or vaccines -here's where things stand}}
		,
	author={{
			JaimyLee
		}}
		
			,
	year={2020. May 6, 2020}
		
	
	,
	note={Market watch [Online. Cited:June 1, 2020.}

}

@book{b35,
	
	
		,
	title={{Emergence of genomic diversity and recurrent mutations in SARS-CoV-2. s.l.: Infection, Genetics and Evolution 104351}}
		,
	author={{
			LucyVanDorp
		} and {
			Acman
		} and {
			Mislav
		} and {
			DamienRichard
		}}
		
		
		
		10.1016/j.meegid.2020.104351
		
		
			,
	year={2020}
		
	

}

@incollection{b36,
	
	
		,
	title={{sci-tech/health/coronavirusaround-30-indian-attempts-at-covid-19-vaccinesays-principal-scientific-adviser/article31560932}}
		,
	author={{
			Coronavirus
		}}
		
	
	
		,
	booktitle={{The Hindu}}
				
			,
	year={2020. May 11, 2020}
		
	
	,
	note={Around 30 Indian attempts at COVID-19 vaccine, says Principal Scientific Adviser}

}

@book{b37,
	
	
		,
	title={{Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection}}
		,
	author={{
			Anon
		}}
		COVID-19
		
			,
	year={2020g}
		
	

}

@book{b38,
	
	
		,
	title={{Human Challenge Studies to Accelerate Coronavirus Vaccine Licensure. s.l.: The Journal of infectious diseases}}
		,
	author={{
			NEyal
		} and {
			MLipsitch
		} and {
			PGSmith
		}}
		
		
		10.1093/infdis/jiaa152
		
		
			,
	year={2020}
			
		
	

}